Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep;6(5):10.1128/microbiolspec.mtbp-0010-2016.
doi: 10.1128/microbiolspec.MTBP-0010-2016.

Transmission Surveillance for Antimicrobial-Resistant Organisms in the Health System

Johann D D Pitout  1
Affiliations
Review

Transmission Surveillance for Antimicrobial-Resistant Organisms in the Health System

Johann D D Pitout. Microbiol Spectr. 2018 Sep.

Abstract

Surveillance of antibiotic resistance involves the collection of antibiotic susceptibility patterns undertaken by clinical microbiology laboratories on bacteria isolated from clinical specimens. Global surveillance programs have shown that antibiotic resistance is a major threat to the public at large and play a crucial role in the development of enhanced diagnostics as well as potential vaccines and novel antibiotics with activity against antimicrobial-resistant organisms. This review focuses primarily on examples of global surveillance systems. Local, national, and global integrated surveillance programs with sufficient data linkage between these schemes, accompanied by enhanced genomics and user-friendly bioinformatics systems, promise to overcome some of the stumbling blocks encountered in the understanding, emergence, and transmission of antimicrobial-resistant organisms.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Medina E, Pieper DH. 2016. Tackling threats and future problems of multidrug-resistant bacteria. Curr Top Microbiol Immunol 398:3–33. 10.1007/82_2016_492. - DOI - PubMed
    1. Huskins WC. 2007. Interventions to prevent transmission of antimicrobial-resistant bacteria in the intensive care unit. Curr Opin Crit Care 13:572–577. 10.1097/MCC.0b013e3282efc30e. [PubMed] - DOI - PubMed
    1. Infectious Diseases Society of America. 2010. The 10 × ’20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Clin Infect Dis 50:1081–1083. 10.1086/652237. [PubMed] - DOI - PubMed
    1. Baker S. 2015. Infectious disease. A return to the pre-antimicrobial era? Science 347:1064–1066. 10.1126/science.aaa2868. [PubMed] - DOI - PubMed
    1. Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y. 2006. Clinical and economic impact of bacteremia with extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 50:1257–1262. 10.1128/AAC.50.4.1257-1262.2006. [PubMed] - DOI - PMC - PubMed

Substances

LinkOut - more resources